Research summary
Berberine and Fasting Glucose in Type 2 Diabetes
In adults with type 2 diabetes, pooled randomized-trial evidence suggests berberine may be associated with lower fasting blood glucose, although the underlying trials are limited.[1]
Important limitations
The pooled trials show high statistical heterogeneity and are mostly of low-to-moderate quality. The review reports publication-bias concerns. These findings concern adults with type 2 diabetes and do not establish a benefit for people without that condition.[1]
This is general information, not medical advice or a treatment recommendation, and berberine is not a substitute for prescribed therapy.[1]
What the pooled trials report
A meta-analysis of randomized trials in adults with type 2 diabetes suggests that berberine may be associated with lower fasting blood glucose. This evidence is specific to adults with type 2 diabetes, not the general or healthy public.[1]
How strong is the evidence
Current human evidence for berberine and blood glucose comes mainly from small, heterogeneous trials of limited quality, and it does not establish a benefit for people without type 2 diabetes.[1]
References
- Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. Endocrine Journal. 2019. Systematic review and meta-analysis View source →
Read the concise FAQ answer
Use the FAQ when you want the direct answer first, then return here for the full evidence context.
Does berberine lower blood sugar?
In adults with type 2 diabetes, pooled randomized-trial evidence suggests berberine may be associated with lower fasting blood glucose. The underlying trials are limited, and this evidence does not establish a benefit for healthy people or replace prescribed treatment.
Read FAQ →What does berberine do for metabolic health?
Berberine has been studied for several metabolic markers. Pooled trials suggest possible improvements in fasting glucose, blood lipids, and modest weight-related measures in selected populations, while blood-pressure findings are mixed and the overall evidence base has important quality limitations.
Read FAQ →